27662293|t|Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
27662293|a|BACKGROUND: Frontotemporal dementia (FTD) is a heterogeneous disease both at the clinical, genetic, and pathobiological level. The underlying pathological spectrum (termed FTLD, frontotemporal lobar degeneration) is in most cases defined by accumulation of either tau (FTLD-tau) or TDP-43 proteins (FTLD-TDP). Biomarkers to differentiate these subtypes are not yet available, whereas these are essential requirements to study the natural course of disease and for homogeneous inclusion of patients in clinical studies. OBJECTIVE: To study if a combination of total (t-) and phosphorylated (p-)tau, and t-TDP-43 and p-TDP-43 proteins in cerebrospinal fluid (CSF) is suitable to discriminate FTLD-tau and FTLD-TDP subtypes. METHODS: We developed immunoassays for the quantification of t-TDP-43 and p-TDP-43 proteins and used commercially available assays for the quantification of t-tau and p-tau proteins. We quantified these proteins in ventricular CSF samples from neuropathologically defined FTLD-tau and FTLD-TDP cases to study the reflection of underlying brain pathology in CSF composition, and in lumbar CSF samples from FTLD-tau and FTLD-TDP patients to study the diagnostic potential of CSF biomarkers. RESULTS: In ventricular CSF, t-TDP-43 and t-tau levels, when combined into one model, were significantly different between neuropathologically-defined FTLD-tau and FTLD-TDP cases. In a pilot study using lumbar CSF, the p-tau/t-tau ratio, but not t-TDP-43 levels, were significantly different between FTLD-TDP and FTLD-tau patients. CONCLUSION: We conclude that with current available methods, CSF tau, rather than TDP-43 proteins, may have diagnostic value in the differentiation of FTLD patients with either tau or TDP-43 pathology.
27662293	0	3	Tau	Gene	4137
27662293	16	22	TDP-43	Gene	23435
27662293	81	114	Frontotemporal Lobar Degeneration	Disease	MESH:D057174
27662293	152	175	Frontotemporal dementia	Disease	MESH:D057180
27662293	177	180	FTD	Disease	MESH:D057180
27662293	312	316	FTLD	Disease	MESH:D057174
27662293	318	351	frontotemporal lobar degeneration	Disease	MESH:D057174
27662293	404	407	tau	Gene	4137
27662293	409	417	FTLD-tau	Disease	MESH:D057174
27662293	422	428	TDP-43	Gene	23435
27662293	439	447	FTLD-TDP	Disease	MESH:D057180
27662293	629	637	patients	Species	9606
27662293	733	736	tau	Gene	4137
27662293	830	838	FTLD-tau	Disease	MESH:D057174
27662293	843	851	FTLD-TDP	Disease	MESH:D057180
27662293	1031	1034	tau	Gene	4137
27662293	1134	1142	FTLD-tau	Disease	MESH:D057174
27662293	1147	1155	FTLD-TDP	Disease	MESH:D057180
27662293	1267	1275	FTLD-tau	Disease	MESH:D057174
27662293	1280	1288	FTLD-TDP	Disease	MESH:D057180
27662293	1289	1297	patients	Species	9606
27662293	1502	1510	FTLD-tau	Disease	MESH:D057174
27662293	1515	1523	FTLD-TDP	Disease	MESH:D057180
27662293	1572	1575	tau	Gene	4137
27662293	1651	1659	FTLD-TDP	Disease	MESH:D057180
27662293	1664	1672	FTLD-tau	Disease	MESH:D057174
27662293	1673	1681	patients	Species	9606
27662293	1748	1751	tau	Gene	4137
27662293	1765	1771	TDP-43	Gene	23435
27662293	1834	1838	FTLD	Disease	MESH:D057174
27662293	1839	1847	patients	Species	9606
27662293	1860	1863	tau	Gene	4137
27662293	1867	1873	TDP-43	Gene	23435
27662293	Association	MESH:D057174	4137
27662293	Association	MESH:D057174	23435

